Get the Stockscreener App
291.88
0.66%
-1.95
After Hours:
292.00
0.12
+0.04%
Overview
News
Price History
Option Chain
Financials
Why CI Down?
Discussions
Forecast
Stock Split
Dividend History
Cigna Group stock is traded at $291.88, with a volume of 1.08M.
It is down -0.66% in the last 24 hours and up +2.32% over the past month.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
See More
Previous Close:
$293.83
Open:
$295.68
24h Volume:
1.08M
Relative Volume:
0.67
Market Cap:
$77.21B
Revenue:
$278.13B
Net Income/Loss:
$6.74B
P/E Ratio:
12.37
EPS:
23.6047
Net Cash Flow:
$7.66B
1W Performance:
-1.06%
1M Performance:
+2.32%
6M Performance:
+5.71%
1Y Performance:
-7.17%
1-Day Range:
$288.37
$295.72
1-Week Range:
$288.37
$299.27
52-Week Range:
$239.51
$338.89
Cigna Group Stock (CI) Company Profile
Name
Cigna Group
Sector
Industry
Phone
(860) 226-6000
Address
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Compare CI vs UNH, CVS, ELV, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
291.88 | 77.73B | 278.13B | 6.74B | 7.66B | 23.60 |
UNH
Unitedhealth Group Inc
|
407.65 | 373.28B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
100.72 | 128.46B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
397.80 | 87.28B | 200.42B | 5.24B | 6.45B | 23.50 |
HUM
Humana Inc
|
369.49 | 45.65B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-26 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-14-25 | Initiated | Goldman | Buy |
| Feb-06-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Feb-05-24 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-05-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-01-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-04-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-11-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| Jun-06-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Neutral |
| Apr-05-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-03-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Nov-21-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Jul-14-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-22-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Hold |
| May-27-22 | Resumed | Bernstein | Mkt Perform |
| May-26-22 | Upgrade | BofA Securities | Underperform → Neutral |
| May-16-22 | Upgrade | JP Morgan | Neutral → Overweight |
| May-09-22 | Upgrade | Cowen | Market Perform → Outperform |
| Feb-07-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-21-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-17-21 | Initiated | Seaport Research Partners | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Mkt Perform |
| Sep-10-21 | Downgrade | BofA Securities | Buy → Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-06-21 | Reiterated | BofA Securities | Buy |
| Aug-06-21 | Reiterated | Citigroup | Buy |
| Aug-06-21 | Reiterated | Deutsche Bank | Buy |
| Aug-06-21 | Reiterated | Jefferies | Buy |
| Aug-06-21 | Reiterated | Mizuho | Buy |
| Aug-06-21 | Reiterated | Oppenheimer | Outperform |
| Aug-06-21 | Reiterated | Truist | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-04-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-24-20 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-11-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Aug-06-19 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Apr-23-19 | Initiated | UBS | Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-24-18 | Initiated | Edward Jones | Buy |
| Mar-13-18 | Initiated | Bernstein | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Overweight |
| Jan-03-18 | Initiated | Goldman | Neutral |
| Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-22-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-12-17 | Initiated | Credit Suisse | Outperform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-08-17 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
View All
Cigna Group Stock (CI) Latest News
Wolfe Research lowers Cigna stock price target to $315 on pharmacy transition - Investing.com
From $18B in revenue to $275B: How CEO David Cordani transformed Cigna and chose to hand over the keys - Fortune
New employer focus, Cigna SureFit Plus aims to narrow health costs - AD HOC NEWS
Cigna Group Stock (US1255231003): valuation metrics in focus for US health insurer - AD HOC NEWS
Cigna (CI): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Cigna Group Announces New CEO; Wall Street Admits Surprise But Remains Bullish - Stocktwits
Cigna Group Stock (US1255231003): Valuation metrics draw Friday focus - AD HOC NEWS
Cigna's Express Scripts sues to block pharmacy ownership law in Tennessee - Reuters
[144] Cigna Group SEC Filing - Stock Titan
Why (CI) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Cigna's Express Scripts sues to block law on prescription access in Tennessee - marketscreener.com
Cigna Group Stock (US1255231003): Valuation metrics draw fresh attention on Wall Street - AD HOC NEWS
Sciencast Management LP's The Cigna Group(CI) Holding History - GuruFocus
Swiss National Bank Sells 38,600 Shares of Cigna Group $CI - MarketBeat
Chancellor Financial Group WB LP's The Cigna Group(CI) Holding History - GuruFocus
Cigna SureFit: Local-focused health plan for value-conscious employers - AD HOC NEWS
Parnassus Investments LLC Has $92.37 Million Stock Holdings in Cigna Group $CI - MarketBeat
Cigna (CI) Faces Cuts in GLP-1 Weight Loss Drug Coverage Amid Ri - GuruFocus
Some US employers to drop coverage of GLP-1 obesity drugs in 2027 as use increases - Reuters
With Aetna and Cigna out, what are your Florida Obamacare options now? - The Palm Beach Post
Financiere des Professionnels Fonds d investissement inc. Acquires 7,319 Shares of Cigna Group $CI - MarketBeat
Cigna Healthcare’s behavioral health: A smart path to lower costs and strengthening workforces - The Business Journals
Loneliness in America 2025 - The Cigna Group Newsroom
Cigna Group stock (US1255231003): Why investors are watching health plan and benefits trends - AD HOC NEWS
GILC Convenes World Leaders on Social Connection and Division During Global Loneliness Awareness Week - GlobeNewswire Inc.
Top 10: Health Insurance Companies - Healthcare Digital
Fox Run Management L.L.C. Buys Shares of 4,280 Cigna Group $CI - MarketBeat
Cigna Group $CI Shares Sold by Erste Asset Management GmbH - MarketBeat
Brandes Investment Partners LP Has $259.89 Million Stock Position in Cigna Group $CI - MarketBeat
The Cigna Group recognized for innovation in health care experiences - The Cigna Group Newsroom
Mizuho Sees Improved Regulatory Stability, Raises Cigna (CI) Price Objective - Insider Monkey
Cigna Group stock outperforms competitors on strong trading day - MarketWatch
The Cigna Group stock (US1255091092): Healthcare insurer in focus after latest earnings and outlook - AD HOC NEWS
Cigna to pull out of individual health market, affecting thousands in Colorado - Colorado Politics
Bernstein Maintains Cigna Group(CI.US) With Buy Rating, Maintains Target Price $371 - Moomoo
Marks Group Wealth Management Inc Sells 12,826 Shares of Cigna Group $CI - MarketBeat
O Shaughnessy Asset Management LLC Grows Stock Position in Cigna Group $CI - MarketBeat
Capital World Investors Increases Stake in Cigna Group $CI - MarketBeat
CI Maintains Rating by Mizuho -- Price Target Raised to $340 - GuruFocus
Dr. Amy Flaster: Most Influential Clinical Executives 2026 - Modern Healthcare
Americans paying the price for Medicare Advantage abuse - Washington Times
Humana Sparks Managed Care Rally As Insurers Regain Momentum - Kalkine Media
Cigna Group stock (US1255231003): health insurer navigates evolving US healthcare landscape - AD HOC NEWS
Dr. Amy Flaster named among Modern Healthcare’s 50 Most Influential Clinical Executives - The Cigna Group Newsroom
Mizuho Securities Maintains Cigna Group(CI.US) With Buy Rating, Raises Target Price to $340 - Moomoo
Mizuho Adjusts Price Target on Cigna Group to $340 From $330, Maintains Outperform Rating - marketscreener.com
More than 40,000 Coloradans will need a new health insurance carrier next year. Here’s who is affected. - The Colorado Sun
Lyrical Asset Management LP Sells 35,341 Shares of Cigna Group $CI - MarketBeat
Capital Research Global Investors Sells 1,245,656 Shares of Cigna Group $CI - MarketBeat
BI Asset Management Fondsmaeglerselskab A S Sells 16,706 Shares of Cigna Group $CI - MarketBeat
Cigna drops coverage of GLP-1 obesity drugs for its own employees - Lee News Central
Cigna Group Stock (CI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.02%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):